Sentence examples for has either developed from inspiring English sources

According to Stephen Sigmon, an analyst with Dain Rauscher Wessels, Vignette is on track to achieve "one-stop shop" status, the ability to furnish most software needs to customers, through its V/5 series, which is being rolled out slowly, and the array of applications that the company has either developed on its own or added through acquisitions.

Mr. Rumsfeld said the Pentagon believed that several nations that support international terrorists have either developed or are trying to acquire chemical, biological or nuclear weapons, and that the dissemination of those weapons seemed a realistic concern.

Syngenta, Monsanto and BASF are among companies that have either developed or are researching pesticides on the nano-scale that they claim will be more stable, longer-lasting and deadlier to pests.

His biography at the Web site of Victoria & Albert Museum offers some clues: "His interest in photography had either developed previously in India, or was sparked by the 1851 Great Exhibition in Hyde Park.

In response, several companies, including Delphi, Infiniti/Nissan, Qualcomm, Plugless Power, Rolls-Royce and WiTricity, have either developed or tested wireless technology that only requires drivers of electric vehicles to park above a pad in a garage floor or parking space to power up.

Across the board, the medical institutions Happtique is working with have either developed their own mobile apps or are in the process of developing their own apps, which is reflection of where hospitals are today, said Cory Ackerman, President of Happtique.

As a result, several companies including Delphi, Nissan, Qualcomm, and Rolls-Royce have either developed or tested wireless charging technology that requires drivers of electric vehicles to merely park above a device embedded in a garage floor or parking space that enables them to power up with little to no effort.

Sign up now Theget the best of VICE Canada deliveraccoonaighadto your inbox.

This suggests that significant changes in the tumour have either developed, or become evident through selection after as few as three cycles of chemotherapy.

Thus far most clinical sequencing analysis pipelines have been driven by individual laboratories, who have either developed their own bioinformatics capability for processing data, relied on commercial products or have partnered with research institutions to acquire the expertise needed.

This might be achieved by examining the length of the intervals between BO diagnosis and incident OAC in very large BO follow-up cohorts and wait until all patients had either developed OAC or died from unrelated causes.